Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar;2(1):10-22.
doi: 10.1016/j.jobb.2020.02.001. Epub 2020 Mar 30.

Deliberate release: Plague - A review

Affiliations
Review

Deliberate release: Plague - A review

Issmaeel Ansari et al. J Biosaf Biosecur. 2020 Mar.

Abstract

Yersinia pestis is the causative agent of plague and is considered one of the most likely pathogens to be used as a bioweapon. In humans, plague is a severe clinical infection that can rapidly progress with a high mortality despite antibiotic therapy. Therefore, early treatment of Y. pestis infection is crucial. This review provides an overview of its clinical manifestations, diagnosis, treatment, prophylaxis, and protection requirements for the use of clinicians. We discuss the likelihood of a deliberate release of plague and the feasibility of obtaining, isolating, culturing, transporting and dispersing plague in the context of an attack aimed at a westernized country. The current threat status and the medical and public health responses are reviewed. We also provide a brief review of the potential prehospital treatment strategy and vaccination against Y. pestis. Further, we discuss the plausibility of antibiotic resistant plague bacterium, F1-negative Y. pestis, and also the possibility of a plague mimic along with potential strategies of defense against these. An extensive literature search on the MEDLINE, EMBASE, and Web of Science databases was conducted to collate papers relevant to plague and its deliberate release. Our review concluded that the deliberate release of plague is feasible but unlikely to occur, and that a robust public health response and early treatment would rapidly halt the transmission of plague in the population. Front-line clinicians should be aware of the potential of a deliberate release of plague and prepared to instigate early isolation of patients. Moreover, front-line clinicians should be weary of the possibility of suicide attackers and mindful of the early escalation to public health organizations.

Keywords: Antibiotic resistant plague; Biowarfare; Bioweapon; Deliberate release; Plague; Plague mimic; Y. pestis.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Axillary and inguinal buboes in patients with bubonic plague.
Fig. 2
Fig. 2
Digital gangrene and gangrene of the right foot.
Fig. 3
Fig. 3
Chest radiographs of two patients with pneumonic plague.

References

    1. Perry R.D., Fetherston J.D. Yersinia pestis–etiologic agent of plague. Clin Microbiol Rev. 1997;10(1):35–66. - PMC - PubMed
    1. Pechous R.D., Sivaraman V., Stasulli N.M., Goldman W.E. Pneumonic Plague: The Darker Side of Yersinia pestis. Trends Microbiol. 2016;24(3):190–197. - PubMed
    1. GoW Consultants. WHO; WHO: 1970. Health aspects of chemical and biological weapons.
    1. Demeure C.E., Dussurget O., Mas Fiol G., Le Guern A.S., Savin C., Pizarro-Cerdá J. Yersinia pestis and plague: an updated view on evolution, virulence determinants, immune subversion, vaccination, and diagnostics. Genes Immun. 2019 - PMC - PubMed
    1. Andersson J. Combating Plague: Fighting a War on Two Fronts Through Vaccine Design and New Therapeutic Intervention. Doctoral Dissertation. UTMB Health: UTMB. Health. 2017

LinkOut - more resources